Scholar Rock prices $300M upsized public offering of common stock and pre-funded warrants

Scholar Rock Holding Corp

Gross proceeds ~$300M; 10,265,488 shares at $28.25/share and 353,983 pre-funded warrants at $28.2499 each.
Underwriters granted 30-day option to purchase up to 1,592,920 additional shares (15% of offering).
Net proceeds ~$282.3M after underwriting discounts and expenses; expected to fund operations into Q4 2026.
Proceeds to support apitegromab commercialization, clinical programs, platform development, and working capital.
Offering expected to close October 10, 2024, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.